Home >Product >Talazoparib
Talazoparib
Talazoparib
CAS No.:1207456-01-6
Molecular Formula:C19H14F2N6O
Molecular Weight:380.36
PRODUCT NAME:Talazoparib

Talazoparib(1207456-01-6) is a pharmaceutical compound used in the treatment of certain types of cancer, primarily breast cancer. It is not typically available in a powder form for consumer use. Talazoparib is classified as a poly (ADP-ribose) polymerase (PARP) inhibitor, which means it interferes with the activity of PARP enzymes in cancer cells, ultimately leading to the death of these cells.

Here is a general product description for Talazoparib:

Product Name: Talazoparib

Chemical Formula: C19H14F2N6O

Molecular Weight: Approximately 395.34 g/mol

Mechanism of Action: Talazoparib inhibits PARP enzymes, which are involved in repairing damaged DNA in cells. By blocking this repair mechanism, Talazoparib can cause DNA damage to accumulate in cancer cells, leading to their death.

Indications: Talazoparib is primarily used for the treatment of HER2-negative, locally advanced or metastatic breast cancer with germline BRCA1/2 mutations. It may be prescribed when other treatment options have not been effective.

Dosage Form: Talazoparib is typically available as an oral tablet or capsule, rather than in a powder form.

Usage: Patients should take Talazoparib exactly as prescribed by their healthcare provider. It is essential to follow the dosing schedule and instructions provided by your medical team.

Side Effects: Common side effects of Talazoparib may include nausea, fatigue, anemia, low white blood cell count, and others. Your healthcare provider will monitor you for potential side effects and adjust your treatment as necessary.

Availability: Talazoparib is a prescription medication and should only be used under the guidance of a qualified healthcare professional. It is not available over the counter, and the form in which it is supplied can vary by manufacturer and country.

 

Product Name

Talazoparib

Batch number

230901

CAS Number

1207456-01-6

Batch weight

210g

Molecular Formula

C1 9H 14F2N6O

Mfg date

Sep,22,2023

Molecular Weight

380.36

Retest date

Sep,21,2025

 

 

 

 

TEST ITEMS

SPECIFICATION

RESULT

Descrption

White to off-white crystal powder

white crystal powder

Identification

BY HPLC

Complies

Melting point

247~249

247.5~248.5

Loss on drying

N.M.T 0.5%

0.2%

Residue on ignition

N.M.T 0.1%

0.03%

Purity (HPLC)

N.L.T 98.0%

99.3%

CONCLUSION

The product complies with the requirements of enterprise standard

Have Questions about Arshine Pharma?
Our professional sales team are waiting for your consultation.

INFORMATION

Sign up to receive our weekly newsletter